

Can't find Xeloda at your pharmacy? Here are practical tools and tips to find Capecitabine in stock near you, including Medfinder and specialty options.
When you're undergoing cancer treatment, the last thing you need is the added stress of hunting for your medication. But for many patients prescribed Xeloda (Capecitabine), that's exactly what's happening. Pharmacies are running low, backorders are common, and you're left wondering where to turn.
The good news: there are specific tools and strategies that can help you find Xeloda in stock faster. This guide walks you through the most effective approaches so you can spend less time searching and more time focusing on your health.
Before diving into solutions, it helps to understand the problem. Capecitabine — the generic name for Xeloda — has faced intermittent shortages since 2022. Manufacturing disruptions at generic producers, raw material supply issues, and growing demand for oral chemotherapy have all contributed to spotty availability. Not every pharmacy is affected equally, which means the medication may be available somewhere nearby even when your usual pharmacy is out.
The fastest way to find Xeloda near you is to use Medfinder. Instead of calling pharmacy after pharmacy, Medfinder lets you search for pharmacies that currently have Capecitabine in stock in your area.
Here's how to use it:
This saves you the time and frustration of calling around, especially when you're managing treatment side effects and appointments. Many patients find Capecitabine in stock within their area on the first search.
When major chain pharmacies — like CVS, Walgreens, or Rite Aid — are out of stock, independent pharmacies and specialty oncology pharmacies are often your best bet. Here's why:
Ask your oncologist's office which pharmacies they recommend. They often have established relationships with pharmacies that reliably stock cancer medications.
Pharmacy inventory fluctuates throughout the week. A few timing strategies can improve your chances:
If the strategies above haven't worked, here are additional options to explore:
Your oncology team is your strongest ally. They may be able to:
Mail-order specialty pharmacies like Accredo, OptumRx Specialty, and CVS Specialty often maintain larger inventories of oral chemotherapy drugs than retail locations. Your insurance company can tell you which specialty pharmacy is in-network. While shipping may take 2–3 days, these pharmacies often have stock when local options don't.
In some cases, your oncologist may recommend switching to a different medication. For example, intravenous 5-Fluorouracil (5-FU) delivers the same active compound through an infusion center. While it's less convenient, it may be more reliably available during a Capecitabine shortage. Learn about other options in our post on alternatives to Xeloda.
If cost is compounding the availability problem, patient assistance programs can help. Genentech offers co-pay assistance for commercially insured patients, and the Genentech Patient Foundation provides free medication for eligible uninsured patients. Read our full breakdown of savings options for Xeloda.
If you want to verify availability at a particular pharmacy before making the trip, here are your options:
For a step-by-step walkthrough, see our guide on how to check if a pharmacy has Xeloda in stock.
Finding Xeloda in 2026 requires more effort than it should, but you have more options than you might think. Start with Medfinder to quickly identify pharmacies with stock, explore independent and specialty pharmacies, and don't hesitate to involve your oncology team. The key is to act early and not wait until you've run out of medication to start looking.
For more context on what's driving the current situation, read our article on why Xeloda is so hard to find in 2026.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.